Vascular Normalization: A New Window Opened for Cancer Therapies

Ting Yang1, Hongqi Xiao2, Xiaoxia Liu1

  • 1Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, China.

Frontiers in Oncology
|September 3, 2021
PubMed

Insights

Tumor vascular normalization, not antiangiogenic therapy, improves cancer treatment. This approach enhances chemotherapy, radiation, and immunotherapy effectiveness by restoring blood vessels and promoting immune cell infiltration.

Area of Science:

  • Oncology
  • Vascular Biology
  • Immunotherapy

Background:

  • Antiangiogenic therapies for tumor blood vessels show limited success due to side effects like resistance.
  • Aberrant tumor vasculature hinders effective cancer treatment and promotes metastasis.
  • Tumor vascular normalization offers a promising strategy to improve therapeutic outcomes.

Purpose of the Study:

  • To explore molecular mechanisms underlying tumor vascular normalization.
  • To investigate the interplay between vascular normalization and immunotherapy.
  • To identify biomarkers and imaging technologies for optimizing vascular normalization strategies.

Main Methods:

  • Review of preclinical and clinical studies on antiangiogenic and vascular normalizing approaches.
  • Exploration of molecular targets including endothelial cell metabolism, microRNAs, and extracellular matrix.
  • Analysis of the synergistic effects of immunotherapy and vascular normalization.

Main Results:

  • Tumor vascular normalization reduces invasion and metastasis.
  • Normalization enhances the efficacy of chemotherapy, radiation, and immunotherapy.
  • Immunotherapy-induced vascular normalization boosts immune effector cell infiltration, creating a positive feedback loop.
  • Imaging technologies and serum markers can identify optimal windows for vascular normalization therapy.

Conclusions:

  • Tumor vascular normalization is a superior strategy compared to traditional antiangiogenic approaches.
  • Combining immunotherapy with agents promoting vascular normalization is recommended for enhanced therapeutic benefits.
  • Biomarkers and imaging are crucial for timing and monitoring vascular normalization interventions.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K